Risa Kagan, MD, on bone health prevention in primary care and why baseline bone density testing should come before age 65.
|Articles|January 1, 2021
Supplements and Featured Publications
- Digital Supplement
- Volume 1
- Issue 1
Better for Women Series
Advertisement
Articles in this issue
about 3 years ago
Focus on Pathways: Understanding and Treating Menopauseabout 4 years ago
Supplement: Closing the Gap in Cervical Cancer Screeningalmost 5 years ago
Advances in testing for preterm premature rupture of membranesalmost 5 years ago
Not all HPV genotypes pose same risk for diseaseabout 5 years ago
A New Treatment Option for Trichomoniasis: Single-Dose Secnidazoleover 5 years ago
Chlamydia Screening in the New Wave of COVID-19Advertisement
Related to this article
Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.
Risk factors cast a wide net in preeclampsia prediction, but biomarkers could add precision, according to Dallas Reed, MD.
Risa Kagan, MD, on why the menopause transition is a critical window for bone loss and how women can preserve bone mass.
This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
Advertisement
Advertisement